Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium

Autor: Campbell, Nicholas P., Kunnavakkam, Rangesh, Leighl, Natasha, Vincent, Mark D., Gandara, David R., Koczywas, Marianna, Gitlitz, Barbara J., Agamah, Edem, Thomas, Sachdev P., Stadler, Walter M., Vokes, Everett E., Kindler, Hedy L.
Zdroj: In Lung Cancer October 2012 78(1):76-80
Databáze: ScienceDirect